More on SAPE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (0.0 Score)
- Holders
- Dividends
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (3/31/15 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SAPE Cash Flow Statement

Click line-items for a historical chart and %
Net income
Loss recognized on disposition of fixed assets -29K
Unrealized loss on financial instruments
Unrealized gain on investments
Depreciation expense 23.12M
Amortization of purchased intangible assets 10.43M
Deferred income taxes -6.59M
Stock-based compensation expense 24.44M
Non-cash restructuring charges 0
Accounts receivable -20.38M
Unbilled revenues -27.06M
Prepaid expenses and other current assets -28.13M
Other assets
Accounts payable -793K
Accrued expenses 17.31M
Accrued compensation 19.95M
Accrued restructuring costs
Deferred revenues -6.72M
Long-term liabilities
Net cash provided by operating activities 38.28M
Cash paid for acquisitions, net of cash acquired -13.02M
Purchases of property and equipment and cost of internally developed software -34.39M
Sales and maturities of marketable securities classified as trading
Sales and maturities of marketable securities not classified as trading
Purchases of marketable securities
Cash (paid) received on financial instruments, net 154K
Change in restricted cash 373K
Net cash (used in) provided by investing activities -53.8M
Principal payments under capital lease obligations
Proceeds from credit facilities
Repayment of amounts borrowed under credit facilities
Proceeds from stock option and purchase plans 2.38M
Dividends paid on common stock
Net cash provided by (used in) financing activities -14.21M
Effect of exchange rate changes on cash and cash equivalents 986K
Increase (decrease) in cash and cash equivalents -28.74M
Cash and cash equivalents, at beginning of period 337.63M
Cash and cash equivalents, at end of period 308.89M
Common stock issued as contingent earnout consideration associated with acquisition

Entities mentioned with SAPE

View All Entities